Insider · CIK 0001513422

Beckman Daniella

Reports to the SEC for 7 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001513422

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	VORVor Biopharma Inc. · Stock option (right to buy)A Award	Director	AAward	+53.3K sh	—	—	53,283
2026-06-09	UPBUpstream Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.1K sh	—	—	17,096
2026-02-03	TNGXTango Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−10.2K sh	$12.26	−$125K	184,410
2026-02-03	TNGXTango Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−113 sh	$12.90	−$1,457.372	184,297
2026-02-02	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+266K sh	—	—	265,980
2026-02-02	TNGXTango Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+44.3K sh	—	—	194,614
2025-07-17	Blueprint Medicines CorpU Disposition from Tender	Director	UDisposition from Tender	−10.8K sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,000 sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,570 sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,300 sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,300 sh	—	—	0
2025-07-17	Blueprint Medicines CorpD Disposition to Issuer	Director	DDisposition to Issuer	−3,902 sh	—	—	10,842
2025-06-18	Blueprint Medicines CorpA Award	Director	AAward	+3,902 sh	$128.12	+$500K	14,744
2025-06-10	UPBUpstream Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.1K sh	—	—	17,096
2025-05-22	VORVor Biopharma Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-02-05	TNGXTango Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−3,948 sh	$3.16	−$12.5K	150,284
2025-02-04	TNGXTango Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−4,284 sh	$2.99	−$12.8K	154,232
2025-02-03	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+157K sh	—	—	156,713
2025-02-03	TNGXTango Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+26.1K sh	—	—	158,516
2024-10-10	UPBUpstream Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+34.7K sh	—	—	34,681
2024-06-12	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+4,570 sh	—	—	4,570
2024-06-12	Blueprint Medicines CorpA Award	Director	AAward	+2,242 sh	—	—	10,842
2024-05-23	VORVor Biopharma Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-02-07	TNGXTango Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,817 sh	$12.62	−$22.9K	132,397
2024-02-06	TNGXTango Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−1,908 sh	$12.56	−$24K	134,214
2024-02-01	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+236K sh	—	—	236,475
2024-02-01	TNGXTango Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+39.4K sh	—	—	39,413
2023-06-21	Blueprint Medicines CorpA Award	Director	AAward	+2,600 sh	—	—	8,600
2023-06-21	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+5,300 sh	—	—	5,300
2023-05-26	VORVor Biopharma Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2023-03-01	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+197K sh	—	—	197,051
2023-03-01	TNGXTango Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+32.8K sh	—	—	96,709
2022-06-21	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+5,300 sh	—	—	5,300
2022-06-21	Blueprint Medicines CorpA Award	Director	AAward	+2,600 sh	—	—	6,000
2022-06-14	VORVor Biopharma Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.9K sh	—	—	16,911
2022-02-01	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+150K sh	—	—	150,000
2021-12-08	Blueprint Medicines CorpA Award	Director	AAward	+3,400 sh	—	—	3,400
2021-12-08	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Director	SSale	−18.9K sh	—	—	0
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Director	SSale	−68K sh	—	—	0
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Director	SSale	−18.9K sh	—	—	0
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Director	SSale	−20K sh	—	—	0
2021-08-12	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+380K sh	—	—	380,485
2021-06-16	Translate Bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-02-05	VORVor Biopharma Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.9K sh	—	—	16,900
2020-10-16	5:01 Acquisition Corp.Class B Common StockJ Other	Director	JOther	+30K sh	—	—	30,000
2020-06-16	Translate Bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+18.9K sh	—	—	18,900
2019-06-18	Translate Bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+18.9K sh	—	—	18,900
2014-08-05	IDENIX PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	SVP, CFO and Treasurer	DDisposition to Issuer	−7,500 sh	—	—	0
2014-08-05	IDENIX PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	SVP, CFO and Treasurer	DDisposition to Issuer	−15K sh	—	—	0

Recent filings

Accepted (ET)
Jun 124
Beckman Daniella0001193125-26-269996
SEC(opens sec.gov)
Jun 114
Beckman Daniella0001193125-26-268166
SEC(opens sec.gov)
Feb 44
Beckman Daniella0001193125-26-038072
SEC(opens sec.gov)
Jul 214
Beckman Daniella0001104659-25-069382
SEC(opens sec.gov)
Jun 244
Beckman Daniella0001415889-25-018078
SEC(opens sec.gov)
Jun 124
Beckman Daniella0000950170-25-085381
SEC(opens sec.gov)
May 234
Beckman Daniella0001415889-25-014528
SEC(opens sec.gov)
Feb 64
Beckman Daniella0000950170-25-015696
SEC(opens sec.gov)
Feb 54
Beckman Daniella0000950170-25-014840
SEC(opens sec.gov)
Oct 154
Beckman Daniella0000950170-24-114686
SEC(opens sec.gov)

Companies

Address

500 BOYLSTON STREET, SUITE 1350

BOSTON, MA, 02116